Raphael Townshend, Founder and CEO of Atomic AI, discusses the groundbreaking intersection of AI and RNA in drug discovery. He highlights how AI models, like Atom 1, predict RNA shapes with remarkable accuracy, unlocking potential in treating previously undruggable diseases like cancer. Townshend dives into the significance of RNA in mRNA vaccines and shares insights on overcoming challenges in drug development. Using advanced AI techniques, his work aims to revolutionize the biotech landscape and create effective therapies for a range of conditions.
